SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.84+2.8%Nov 18 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (11149)11/15/1997 12:27:00 PM
From: JOHN W.  Read Replies (2) of 32384
 
< Others have criticized their burn rate, but their $200 million deal with LLY should taken them through profitability in 1999. Others have also complained about share dilution, but I view that as a necessary evil required to take LGND into the fully integrated pharmaceutical category. >

Thes necessary evils are just that, necessary for the small investor long term to get burned and possibly lose all their capital, due to a company like LGND that has one of the highest burn rates in the sector, little cash, a questionable "deal" with big pharma that did not impress the street, and a vault full of shares to continue to offer that will slowly suck out in worth of the long term investors as you have already bailed because you know their chance of ever making high sustained revenues,0.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext